Madrigal Pharmaceuticals (MDGL) EPS (Basic) (2010 - 2026)
Madrigal Pharmaceuticals' (MDGL) quarterly EPS (Basic) came in at -$3.18 in Q1 2026, up 4.1% year-on-year from -$3.05 in Q1 2025, and up 58.53% on a QoQ basis from -$7.67 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) EPS (Basic) (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 17 years of EPS (Basic) data on file, last reported at -$3.18 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 4.1% year-over-year to -$3.18 in Q1 2026; TTM through Mar 2026 was -$14.39, a 15.93% increase from a year earlier, with the FY2025 full-year figure at -$38.06, up 15.67% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$3.18, up from -$7.67 in the prior quarter.
- Over the last five years, EPS (Basic) for MDGL reached as high as -$1.9 in Q2 2025 and fell as low as -$7.67 in Q4 2025.
- Historically, EPS (Basic) has averaged -$4.71 across 5 years, with a median of -$4.75 in 2022.
- On a YoY basis, EPS (Basic) climbed as much as 73.21% in 2025 and fell as far as 255.71% in 2025.
- Year by year, EPS (Basic) stood at -$5.01 in 2022, then decreased by 19.77% to -$6.0 in 2023, then surged by 64.1% to -$2.16 in 2024, then slumped by 255.71% to -$7.67 in 2025, then jumped by 58.53% to -$3.18 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$3.18 in Q1 2026, -$7.67 in Q4 2025, and -$4.94 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Madrigal Pharmaceuticals | 15.79 Bn | 15.56 Bn | - | -3.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.18 |
| Dec 31, 2025 | -7.67 |
| Sep 30, 2025 | -4.94 |
| Jun 30, 2025 | -1.90 |
| Mar 31, 2025 | -3.32 |
| Dec 31, 2024 | -2.16 |
| Sep 30, 2024 | -4.92 |
| Jun 30, 2024 | -7.10 |
| Mar 31, 2024 | -7.38 |
| Dec 31, 2023 | -6.00 |
| Sep 30, 2023 | -5.34 |
| Jun 30, 2023 | -4.69 |
| Mar 31, 2023 | -4.23 |
| Dec 31, 2022 | -5.01 |
| Sep 30, 2022 | -4.75 |
| Jun 30, 2022 | -4.14 |
| Mar 31, 2022 | -3.36 |
| Dec 31, 2021 | -3.90 |
| Sep 30, 2021 | -3.79 |
| Jun 30, 2021 | -3.72 |